Standard BioTools Analyst Ratings
Standard BioTools Analyst Ratings
While ratings are subjective and will change, the latest Standard BioTools (LAB) rating was a initiated with a price target of $0.00 to $4.00. The current price Standard BioTools (LAB) is trading at is $2.28, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/12/2023 | 75.44% | Keybanc | → $4 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 07/12/2023 | 75.44% | Keybanc | → 4 美元 | 啓動覆蓋開啓 | → 超重 |
What is the target price for Standard BioTools (LAB)?
Standard BioTools (LAB) 的目標價格是多少？
The latest price target for Standard BioTools (NASDAQ: LAB) was reported by Keybanc on July 12, 2023. The analyst firm set a price target for $4.00 expecting LAB to rise to within 12 months (a possible 75.44% upside). 1 analyst firms have reported ratings in the last year.
Keybanc於2023年7月12日公佈了標準BioTools（納斯達克股票代碼：LAB）的最新目標股價。這家分析公司將目標股價定爲4.00美元，預計LAB將在12個月內升至4美元（可能上漲75.44％）。去年有1家分析公司公佈了評級。
What is the most recent analyst rating for Standard BioTools (LAB)?
分析師對標準 BioTools (LAB) 的最新評級是多少？
The latest analyst rating for Standard BioTools (NASDAQ: LAB) was provided by Keybanc, and Standard BioTools initiated their overweight rating.
Standard BioTools（納斯達克股票代碼：LAB）的最新分析師評級由Keybanc提供，Standard BioTools啓動了增持評級。
When is the next analyst rating going to be posted or updated for Standard BioTools (LAB)?
Standard BioTools (LAB) 的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Standard BioTools, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Standard BioTools was filed on July 12, 2023 so you should expect the next rating to be made available sometime around July 12, 2024.
分析師在進行了廣泛的研究（包括瀏覽公開財務報表、與Standard BioTools的高管和客戶交談以及聽取財報電話會議）後得出了股票評級。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。Standard BioTools的最新評級是在2023年7月12日提交的，因此您應該預計下一個評級將在2024年7月12日左右公佈。
Is the Analyst Rating Standard BioTools (LAB) correct?
分析師評級標準 BioTools (LAB) 正確嗎？
While ratings are subjective and will change, the latest Standard BioTools (LAB) rating was a initiated with a price target of $0.00 to $4.00. The current price Standard BioTools (LAB) is trading at is $2.28, which is within the analyst's predicted range.
雖然評級是主觀的，會發生變化，但最新的標準BioTools（LAB）評級是最初的，目標股價爲0.00美元至4.00美元。Standard BioTools（LAB）目前的交易價格爲2.28美元，在分析師的預測區間內。
